These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8513605)

  • 1. Tonsillar carcinoma in a renal graft recipient treated with cyclosporine A.
    Swoboda A; Fabrizii V
    Clin Nephrol; 1993 May; 39(5):272-4. PubMed ID: 8513605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery.
    Hsu HJ; Tian YC; Chen YC; Lai BC; Fang JT; Yang CW; Wu MS
    Ren Fail; 2008; 30(3):303-6. PubMed ID: 18350450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A; Druskis V; Laurinavicius A
    Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term maintenance of calcineurin inhibitor monotherapy reduces the risk for squamous cell carcinomas after kidney transplantation compared with bi- or tritherapy.
    Abou Ayache R; Thierry A; Bridoux F; Bauwens M; Belmouaz M; Desport E; Touchard G
    Transplant Proc; 2007 Oct; 39(8):2592-4. PubMed ID: 17954185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre.
    McGeown MG; Douglas JF; Middleton D
    Clin Transpl; 2000; ():193-202. PubMed ID: 11512313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tonsillar carcinoma in the early postoperative course following heart transplantation.
    Gummert JF; Falk V; Walther T; Diegeler A; Baryalei M; Mohr FW; Dalichau H
    Thorac Cardiovasc Surg; 1995 Dec; 43(6):355-7. PubMed ID: 8775862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
    Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P
    Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of a kidney with a renal cell carcinoma after living donation: a case report.
    Ghafari A
    Transplant Proc; 2007 Jun; 39(5):1660-1. PubMed ID: 17580211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of oropharyngeal cancer in renal transplant recipients without cessation of immunosuppressive therapy.
    Singh SK; Gupta AK; Jha V; Kohli HS; Gupta KL; Minz M; Sakhuja V
    Transplant Proc; 2006 Sep; 38(7):2088-9. PubMed ID: 16980008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
    Lucan M; Iacob G; Lucan C; Lăpuşan C; Munteanu A; Sîrbu S
    Transplant Proc; 2004 Mar; 36(2 Suppl):177S-180S. PubMed ID: 15041332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
    He X; Johnston A
    Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.